I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Phase 2 Study of SAR439859 Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer (AMEERA-3)
To evaluate the PFS according to the estrogen receptor 1 gene (ESR1) mutation status in the 2 treatment arms. To evaluate the pharmacokinetics of SAR439859 as single agent. To evaluate health related quality of life in the 2 treatment arms.
breast adenocarcinoma
anastrozole
cancer metastatic
endocrine therapy
hormone therapy
- 0 views
- 04 Dec, 2020
- 126 locations